MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

Abbott Laboratories

Fermé

SecteurSoins de santé

123.73 2.37

Résumé

Variation du prix de l'action

24h

Actuel

Min

123.53

Max

124.48

Chiffres clés

By Trading Economics

Revenu

-7.9B

1.3B

Ventes

-616M

10B

P/E

Moyenne du Secteur

17.147

39.857

BPA

1.09

Rendement du dividende

1.74

Marge bénéficiaire

12.792

Employés

114,000

EBITDA

-324M

2.7B

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+17.79% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.74%

2.42%

Prochains Résultats

15 oct. 2025

Date du Prochain Dividende

15 août 2025

Date du Prochain Détachement de Dividende

14 oct. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

1.9B

230B

Ouverture précédente

121.36

Clôture précédente

123.73

Sentiment de l'Actualité

By Acuity

41%

59%

138 / 376 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Weak Bullish Evidence

Abbott Laboratories Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

17 juil. 2025, 12:10 UTC

Résultats

Abbott Labs Pares Outlook, Logs 2Q Profit Gains

16 avr. 2025, 16:21 UTC

Résultats

Abbott Labs Bracing for Tariffs as Profits Rise -- Update

16 avr. 2025, 12:14 UTC

Résultats

Abbott Labs 1Q Profit Jumps on Gains in Nutrition, Medical Devices

17 juil. 2025, 13:14 UTC

Résultats

Abbott Labs Stock Falls After Earnings. Why Rising Sales Fail to Lift Shares. -- Barrons.com

17 juil. 2025, 12:16 UTC

Résultats

Abbott Labs Stock Dives After Earnings Miss. Why Rising Sales Fail to Lift Shares. -- Barrons.com

17 juil. 2025, 11:32 UTC

Résultats

Abbott Labs Sees 3Q Adj EPS $1.28-Adj EPS $1.32 >ABT

17 juil. 2025, 11:32 UTC

Résultats

Abbott Labs: See Momentum Carrying Into 2026 >ABT

17 juil. 2025, 11:31 UTC

Résultats

Abbott Labs Sees 2025 Organic Sales Up 7.5%-8%, Excluding Covid-19 Testing-Related Sales >ABT

17 juil. 2025, 11:30 UTC

Résultats

Abbott Labs 2Q Organic Sales Rose 6.9% >ABT

17 juil. 2025, 11:30 UTC

Résultats

Abbott Labs 2Q Adjusted Operating Margin 22.9% >ABT

17 juil. 2025, 11:30 UTC

Résultats

Abbott Labs 2Q Adjusted Gross Margin 57% >ABT

17 juil. 2025, 11:30 UTC

Résultats

Abbott Labs 2Q Organic Sales Growth Up 6.9% >ABT

17 juil. 2025, 11:30 UTC

Résultats

Abbott Labs 2Q Sales $11.14B >ABT

17 juil. 2025, 11:30 UTC

Résultats

Abbott Labs 2Q Net $1.78B >ABT

17 juil. 2025, 11:30 UTC

Résultats

Abbott Labs 2Q Adj EPS $1.26 >ABT

17 juil. 2025, 11:30 UTC

Résultats

Abbott Labs Sees FY Adj EPS $5.10-Adj EPS $5.20 >ABT

17 juil. 2025, 11:30 UTC

Résultats

Abbott Labs 2Q EPS $1.01 >ABT

17 juil. 2025, 09:08 UTC

Actions en Tendance

Stocks to Watch Thursday: TSMC, United Airlines, Sarepta -- WSJ

1 juil. 2025, 18:41 UTC

Acquisitions, Fusions, Rachats

How DexCom, Insulet, and Amedisys Might Be Affected by Medicare Cuts -- Barrons.com

16 avr. 2025, 15:09 UTC

Market Talk

Abbott Says Tariffs Killed Chances of an Outlook Raise -- Market Talk

16 avr. 2025, 14:17 UTC

Résultats

Abbott Laboratories Stock Rises as First-Quarter Earnings Surpass Expectations -- Barrons.com

16 avr. 2025, 11:34 UTC

Résultats

Abbott Labs 1Q Gross Margin of 52.8 % of Sales; Adj Gross Margin of 57.1 % >ABT

16 avr. 2025, 11:33 UTC

Résultats

Abbott Labs Projects FY25 Adj Operating Margin to Be 23.5% to 24.0% of Sales >ABT

16 avr. 2025, 11:32 UTC

Résultats

Abbott Labs Backs FY25 Adj EPS $5.05-Adj EPS $5.25 >ABT

16 avr. 2025, 11:32 UTC

Résultats

Abbott Labs Sees 2Q Adj EPS $1.23-Adj EPS $1.27 >ABT

16 avr. 2025, 11:31 UTC

Résultats

Abbott Labs Projects FY25 Organic Sales Growth of 7.5% to 8.5% >ABT

16 avr. 2025, 11:30 UTC

Résultats

Abbott Reaffirms Full-Yr Guidance

16 avr. 2025, 11:30 UTC

Résultats

Abbott Labs 1Q Organic Sales Growth Up 6.9% >ABT

16 avr. 2025, 11:30 UTC

Résultats

Abbott Labs 1Q Sales $10.36B >ABT

16 avr. 2025, 11:30 UTC

Résultats

Abbott Labs 1Q Net $1.33B >ABT

Comparaison

Variation de prix

Abbott Laboratories prévision

Objectif de Prix

By TipRanks

17.79% hausse

Prévisions sur 12 Mois

Moyen 145.67 USD  17.79%

Haut 159 USD

Bas 135 USD

Basé sur 19 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

19 ratings

16

Achat

3

Maintien

0

Vente

Score Technique

By Trading Central

132.82 / 134.43Support & Résistance

Court Terme

Weak Bullish Evidence

Moyen Terme

Neutral Evidence

Long Terme

Bullish Evidence

Sentiment

By Acuity

138 / 376Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.